Metastatic disease to the parotid gland
Options
Publisher DOI
PubMed ID
17141071
Description
OBJECTIVES: The purpose of this study was to review the clinico-pathologic findings and outcome of patients with metastasis to the parotid lymph nodes and gland. METHODS: Retrospective study. Thirty-four out of 520 patients with a parotid mass treated at our institution met the criteria for this study. Age, gender, clinical findings, histopathology, treatment. and outcome were analyzed. RESULTS: Twenty-three patients had metastases to parotid lymph nodes from a squamous cell carcinoma of the skin, seven from a cutaneous malignant melanoma after a mean interval of 15 months, two from a ductal breast carcinoma, one with a metastatic disease from a rhabdomyosarcoma of the lower limb, and one from a Merkel cell carcinoma. The 5-year cause-specific and absolute survival for squamous cell carcinoma was 64% and 48% respectively and 71% and 57% for malignant melanomas. CONCLUSIONS: Metastatic disease to the parotid gland is mostly caused by squamous cell carcinoma. Despite combined treatment modalities long-term survival remains poor.
Date of Publication
2006
Publication Type
Article
Language(s)
en
Contributor(s)
Nuyens, Michel | |
Schüpbach, Jonas | |
Stauffer, Edouard |
Additional Credits
Series
Otolaryngology - head and neck surgery
Publisher
Sage
ISSN
0194-5998
ISBN
17141071
Access(Rights)
metadata.only